Telemetry 2021 - Cardiovascular Safety Pharmacology: Best Practice Considerations for the In Vivo QTc Core Assay

Who Should Attend?
Drug discovery researchers working on compounds that are intended for human use
Scientists engaged in preclinical safety pharmacology studies
IND program/project managers who field questions related to safety pharmacology requirements, designs, etc.
What You Will Learn
Join this webinar to learn about:
How cardiovascular safety pharmacology study models are validated and verified
How cardiovascular safety pharmacology studies are designed and executed
Exposure-response analysis and understand how and why this might be incorporated into a preclinical study model
Power analysis and understand why this is an important measurement when assessing the strength of a model to detect potential changes